| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 95 | 2025 | 333 | 18.230 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 78 | 2025 | 256 | 12.000 |
Why?
|
| Inflammation | 82 | 2025 | 1110 | 7.650 |
Why?
|
| Macrophages | 66 | 2025 | 1013 | 7.000 |
Why?
|
| Immunity, Innate | 50 | 2024 | 768 | 5.890 |
Why?
|
| Atherosclerosis | 18 | 2022 | 148 | 5.200 |
Why?
|
| Interleukin-1beta | 45 | 2024 | 262 | 4.930 |
Why?
|
| Signal Transduction | 74 | 2024 | 2891 | 4.530 |
Why?
|
| Toll-Like Receptors | 34 | 2025 | 434 | 4.110 |
Why?
|
| Carrier Proteins | 29 | 2023 | 710 | 3.740 |
Why?
|
| Microglia | 18 | 2025 | 229 | 3.460 |
Why?
|
| Animals | 197 | 2025 | 19768 | 3.210 |
Why?
|
| Alzheimer Disease | 19 | 2025 | 560 | 2.600 |
Why?
|
| Mice | 141 | 2025 | 10343 | 2.570 |
Why?
|
| Cholesterol | 13 | 2020 | 255 | 2.240 |
Why?
|
| Cytokines | 32 | 2025 | 911 | 2.240 |
Why?
|
| Caspase 1 | 25 | 2025 | 110 | 2.220 |
Why?
|
| Humans | 229 | 2025 | 60132 | 2.160 |
Why?
|
| Toll-Like Receptor 4 | 26 | 2021 | 348 | 2.130 |
Why?
|
| Mice, Inbred C57BL | 74 | 2025 | 3218 | 2.080 |
Why?
|
| Toll-Like Receptor 9 | 21 | 2024 | 196 | 1.990 |
Why?
|
| Receptors, Cell Surface | 24 | 2022 | 439 | 1.970 |
Why?
|
| Diet, Western | 4 | 2019 | 8 | 1.950 |
Why?
|
| Lysosomes | 18 | 2025 | 163 | 1.930 |
Why?
|
| Interleukin-18 | 15 | 2021 | 74 | 1.920 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 128 | 1.840 |
Why?
|
| Monocytes | 19 | 2021 | 345 | 1.820 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2024 | 148 | 1.780 |
Why?
|
| Interleukin-1 | 11 | 2022 | 155 | 1.740 |
Why?
|
| Membrane Glycoproteins | 22 | 2021 | 669 | 1.700 |
Why?
|
| Inflammation Mediators | 12 | 2021 | 169 | 1.620 |
Why?
|
| Endosomes | 8 | 2021 | 170 | 1.580 |
Why?
|
| DNA | 16 | 2024 | 793 | 1.560 |
Why?
|
| Dendritic Cells | 21 | 2021 | 508 | 1.550 |
Why?
|
| Mice, Knockout | 51 | 2025 | 1999 | 1.530 |
Why?
|
| Immunologic Memory | 6 | 2021 | 284 | 1.470 |
Why?
|
| Lipopolysaccharides | 19 | 2020 | 645 | 1.440 |
Why?
|
| RNA | 5 | 2021 | 405 | 1.420 |
Why?
|
| Immune System | 4 | 2020 | 129 | 1.390 |
Why?
|
| Interferon-beta | 7 | 2021 | 77 | 1.360 |
Why?
|
| CARD Signaling Adaptor Proteins | 14 | 2021 | 63 | 1.320 |
Why?
|
| Cells, Cultured | 38 | 2021 | 2101 | 1.300 |
Why?
|
| Epigenesis, Genetic | 5 | 2020 | 351 | 1.190 |
Why?
|
| Toll-Like Receptor 7 | 12 | 2024 | 96 | 1.190 |
Why?
|
| Cell Line | 44 | 2021 | 2017 | 1.180 |
Why?
|
| HEK293 Cells | 21 | 2024 | 583 | 1.180 |
Why?
|
| Toll-Like Receptor 8 | 9 | 2024 | 44 | 1.170 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 74 | 1.160 |
Why?
|
| Brain | 9 | 2025 | 1493 | 1.150 |
Why?
|
| Receptors, Pattern Recognition | 3 | 2014 | 31 | 1.140 |
Why?
|
| Receptors, Immunologic | 13 | 2014 | 177 | 1.140 |
Why?
|
| Membrane Transport Proteins | 4 | 2024 | 122 | 1.090 |
Why?
|
| Host-Pathogen Interactions | 8 | 2021 | 238 | 1.090 |
Why?
|
| Pyroptosis | 4 | 2021 | 31 | 1.080 |
Why?
|
| Nucleic Acids | 3 | 2016 | 50 | 1.070 |
Why?
|
| Cell Death | 10 | 2024 | 272 | 1.070 |
Why?
|
| NF-kappa B | 17 | 2024 | 462 | 1.040 |
Why?
|
| Adaptive Immunity | 4 | 2021 | 94 | 1.010 |
Why?
|
| Oligodeoxyribonucleotides | 12 | 2021 | 243 | 1.010 |
Why?
|
| Cytoskeletal Proteins | 6 | 2017 | 196 | 1.000 |
Why?
|
| Crystallization | 8 | 2018 | 97 | 0.960 |
Why?
|
| Amyloid beta-Peptides | 11 | 2025 | 195 | 0.950 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2024 | 17 | 0.920 |
Why?
|
| Extracellular Vesicles | 2 | 2022 | 43 | 0.910 |
Why?
|
| Multiprotein Complexes | 5 | 2018 | 154 | 0.910 |
Why?
|
| Flow Cytometry | 13 | 2018 | 639 | 0.900 |
Why?
|
| Phagocytes | 5 | 2018 | 49 | 0.900 |
Why?
|
| Autoimmunity | 5 | 2024 | 221 | 0.860 |
Why?
|
| Adaptor Proteins, Signal Transducing | 14 | 2024 | 419 | 0.840 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2016 | 76 | 0.830 |
Why?
|
| Silicosis | 2 | 2016 | 4 | 0.830 |
Why?
|
| Familial Mediterranean Fever | 1 | 2022 | 9 | 0.820 |
Why?
|
| Immune System Diseases | 2 | 2020 | 17 | 0.820 |
Why?
|
| Microscopy, Fluorescence | 5 | 2016 | 400 | 0.810 |
Why?
|
| Interleukin-6 | 7 | 2023 | 309 | 0.810 |
Why?
|
| Bacterial Toxins | 1 | 2022 | 60 | 0.800 |
Why?
|
| Gene Expression Regulation | 13 | 2019 | 1539 | 0.790 |
Why?
|
| Receptor for Advanced Glycation End Products | 5 | 2016 | 19 | 0.770 |
Why?
|
| Pyrin | 2 | 2022 | 7 | 0.770 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 12 | 0.770 |
Why?
|
| Autoimmune Diseases | 5 | 2016 | 224 | 0.760 |
Why?
|
| DNA-Binding Proteins | 17 | 2025 | 1136 | 0.750 |
Why?
|
| Interferon Type I | 8 | 2023 | 168 | 0.750 |
Why?
|
| Vasculitis | 1 | 2021 | 51 | 0.740 |
Why?
|
| Myeloid Differentiation Factor 88 | 12 | 2021 | 207 | 0.740 |
Why?
|
| Homeostasis | 4 | 2019 | 343 | 0.740 |
Why?
|
| Lipoproteins, HDL | 3 | 2019 | 36 | 0.730 |
Why?
|
| Gastrointestinal Microbiome | 7 | 2022 | 202 | 0.720 |
Why?
|
| HMGB1 Protein | 4 | 2018 | 26 | 0.710 |
Why?
|
| Lipopolysaccharide Receptors | 8 | 2018 | 142 | 0.710 |
Why?
|
| Disulfiram | 1 | 2020 | 5 | 0.710 |
Why?
|
| Bone Marrow Cells | 5 | 2018 | 232 | 0.670 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 22 | 0.670 |
Why?
|
| Biomarkers | 13 | 2024 | 1213 | 0.670 |
Why?
|
| Interferons | 2 | 2018 | 63 | 0.660 |
Why?
|
| Interleukin-1alpha | 4 | 2022 | 25 | 0.660 |
Why?
|
| Bacteria | 3 | 2017 | 278 | 0.650 |
Why?
|
| DNA, Mitochondrial | 2 | 2023 | 78 | 0.650 |
Why?
|
| beta-Cyclodextrins | 2 | 2016 | 25 | 0.640 |
Why?
|
| Ligands | 4 | 2016 | 422 | 0.640 |
Why?
|
| Plaque, Atherosclerotic | 5 | 2021 | 28 | 0.630 |
Why?
|
| Apoptosis | 7 | 2023 | 1040 | 0.630 |
Why?
|
| Protein Binding | 18 | 2021 | 1566 | 0.630 |
Why?
|
| Pneumonia | 3 | 2022 | 272 | 0.620 |
Why?
|
| Exons | 1 | 2019 | 193 | 0.610 |
Why?
|
| Alternative Splicing | 1 | 2019 | 120 | 0.610 |
Why?
|
| Gout | 2 | 2016 | 53 | 0.610 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2024 | 161 | 0.600 |
Why?
|
| Microbiota | 5 | 2022 | 104 | 0.590 |
Why?
|
| Leukocytes, Mononuclear | 7 | 2021 | 240 | 0.590 |
Why?
|
| CpG Islands | 7 | 2010 | 212 | 0.590 |
Why?
|
| Kidney Diseases | 5 | 2021 | 160 | 0.590 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2024 | 158 | 0.590 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 33 | 0.590 |
Why?
|
| Clone Cells | 1 | 2018 | 106 | 0.580 |
Why?
|
| Microscopy, Confocal | 14 | 2019 | 219 | 0.580 |
Why?
|
| Activating Transcription Factor 3 | 2 | 2015 | 7 | 0.580 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 99 | 0.570 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2018 | 74 | 0.570 |
Why?
|
| B-Lymphocytes | 5 | 2014 | 552 | 0.570 |
Why?
|
| Transcription, Genetic | 6 | 2019 | 848 | 0.560 |
Why?
|
| Caspase 8 | 2 | 2019 | 61 | 0.560 |
Why?
|
| Kidney | 6 | 2021 | 397 | 0.560 |
Why?
|
| Histones | 2 | 2019 | 464 | 0.560 |
Why?
|
| Toll-Like Receptor 2 | 14 | 2021 | 220 | 0.550 |
Why?
|
| Disease Models, Animal | 21 | 2025 | 2087 | 0.550 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2024 | 155 | 0.550 |
Why?
|
| Membrane Proteins | 7 | 2024 | 847 | 0.550 |
Why?
|
| Sulfones | 6 | 2019 | 37 | 0.540 |
Why?
|
| Alarmins | 1 | 2016 | 4 | 0.540 |
Why?
|
| Macrophage Activation | 5 | 2021 | 119 | 0.540 |
Why?
|
| Interleukin-33 | 1 | 2016 | 18 | 0.540 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 179 | 0.540 |
Why?
|
| S100 Proteins | 1 | 2016 | 21 | 0.540 |
Why?
|
| Stress, Physiological | 1 | 2018 | 186 | 0.540 |
Why?
|
| Phagocytosis | 10 | 2025 | 252 | 0.530 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 201 | 0.530 |
Why?
|
| Green Fluorescent Proteins | 5 | 2018 | 354 | 0.530 |
Why?
|
| Asbestosis | 1 | 2016 | 1 | 0.520 |
Why?
|
| Autophagy | 5 | 2024 | 208 | 0.520 |
Why?
|
| Aging | 2 | 2019 | 731 | 0.520 |
Why?
|
| Kupffer Cells | 3 | 2025 | 42 | 0.520 |
Why?
|
| tau Proteins | 6 | 2023 | 104 | 0.520 |
Why?
|
| Nuclear Proteins | 8 | 2014 | 760 | 0.510 |
Why?
|
| Furans | 6 | 2022 | 36 | 0.480 |
Why?
|
| Reactive Oxygen Species | 12 | 2025 | 202 | 0.480 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2014 | 2 | 0.470 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2014 | 6 | 0.470 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2014 | 4 | 0.470 |
Why?
|
| Liquid Crystals | 2 | 2020 | 3 | 0.470 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 5 | 2019 | 25 | 0.460 |
Why?
|
| Sulfonamides | 6 | 2022 | 123 | 0.450 |
Why?
|
| Cognitive Dysfunction | 4 | 2023 | 276 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2021 | 584 | 0.440 |
Why?
|
| Interferon Regulatory Factors | 2 | 2013 | 39 | 0.440 |
Why?
|
| Immunotherapy | 2 | 2018 | 237 | 0.440 |
Why?
|
| Apolipoproteins E | 3 | 2016 | 99 | 0.430 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2013 | 22 | 0.430 |
Why?
|
| Genes, Reporter | 6 | 2016 | 243 | 0.430 |
Why?
|
| Antigen Presentation | 6 | 2024 | 228 | 0.430 |
Why?
|
| Endoplasmic Reticulum | 4 | 2019 | 169 | 0.430 |
Why?
|
| Mitochondria | 6 | 2025 | 337 | 0.430 |
Why?
|
| Succinates | 2 | 2024 | 8 | 0.430 |
Why?
|
| fas Receptor | 2 | 2012 | 54 | 0.420 |
Why?
|
| Male | 43 | 2025 | 27971 | 0.420 |
Why?
|
| Shock, Septic | 2 | 2012 | 90 | 0.420 |
Why?
|
| Endoribonucleases | 2 | 2025 | 53 | 0.420 |
Why?
|
| Aorta | 2 | 2022 | 106 | 0.420 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2012 | 9 | 0.400 |
Why?
|
| Clonal Anergy | 1 | 2012 | 23 | 0.400 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 78 | 0.390 |
Why?
|
| Intestines | 2 | 2015 | 156 | 0.390 |
Why?
|
| Lung Diseases | 1 | 2013 | 166 | 0.390 |
Why?
|
| Eosinophils | 2 | 2025 | 53 | 0.390 |
Why?
|
| Fibrosis | 5 | 2019 | 152 | 0.390 |
Why?
|
| Models, Biological | 9 | 2021 | 1143 | 0.390 |
Why?
|
| Transcriptome | 6 | 2021 | 337 | 0.390 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 86 | 0.390 |
Why?
|
| Tetracycline | 2 | 2022 | 20 | 0.390 |
Why?
|
| Cytosol | 5 | 2021 | 170 | 0.380 |
Why?
|
| Nitric Oxide | 1 | 2012 | 144 | 0.380 |
Why?
|
| Neutrophils | 4 | 2021 | 351 | 0.380 |
Why?
|
| alpha-Synuclein | 2 | 2021 | 22 | 0.380 |
Why?
|
| Aortic Diseases | 1 | 2012 | 67 | 0.380 |
Why?
|
| Proteomics | 3 | 2023 | 264 | 0.370 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2024 | 98 | 0.370 |
Why?
|
| Indenes | 6 | 2022 | 17 | 0.370 |
Why?
|
| Disease Progression | 6 | 2025 | 1054 | 0.370 |
Why?
|
| Receptors, LDL | 3 | 2018 | 33 | 0.360 |
Why?
|
| Mice, Transgenic | 11 | 2025 | 1227 | 0.360 |
Why?
|
| Nucleotidyltransferases | 4 | 2024 | 54 | 0.360 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 52 | 0.360 |
Why?
|
| Cell Membrane | 7 | 2013 | 492 | 0.360 |
Why?
|
| Protein Isoforms | 4 | 2019 | 196 | 0.350 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 4 | 2018 | 33 | 0.350 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 172 | 0.350 |
Why?
|
| Glycolysis | 3 | 2020 | 54 | 0.350 |
Why?
|
| Amyloid | 3 | 2020 | 63 | 0.350 |
Why?
|
| Liver | 6 | 2025 | 789 | 0.340 |
Why?
|
| Nucleotides, Cyclic | 3 | 2021 | 13 | 0.330 |
Why?
|
| Aptamers, Nucleotide | 3 | 2019 | 18 | 0.330 |
Why?
|
| Immune Tolerance | 2 | 2021 | 171 | 0.330 |
Why?
|
| Glucocorticoids | 2 | 2024 | 172 | 0.330 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 14 | 0.330 |
Why?
|
| Protein Transport | 5 | 2018 | 398 | 0.330 |
Why?
|
| Protein Multimerization | 5 | 2018 | 171 | 0.330 |
Why?
|
| Female | 32 | 2024 | 31250 | 0.320 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 5 | 2019 | 83 | 0.320 |
Why?
|
| Protein Domains | 3 | 2019 | 141 | 0.320 |
Why?
|
| Killer Cells, Natural | 4 | 2022 | 215 | 0.320 |
Why?
|
| Drosophila Proteins | 6 | 2003 | 682 | 0.320 |
Why?
|
| THP-1 Cells | 5 | 2021 | 17 | 0.310 |
Why?
|
| Uric Acid | 2 | 2021 | 49 | 0.310 |
Why?
|
| Sphingolipids | 2 | 2020 | 23 | 0.310 |
Why?
|
| Myeloid Cells | 3 | 2021 | 92 | 0.310 |
Why?
|
| Caspase Inhibitors | 2 | 2022 | 21 | 0.310 |
Why?
|
| Phosphorylation | 7 | 2021 | 860 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2014 | 261 | 0.310 |
Why?
|
| Macrophages, Peritoneal | 3 | 2021 | 73 | 0.310 |
Why?
|
| DNA, Bacterial | 3 | 2019 | 260 | 0.310 |
Why?
|
| RNA, Double-Stranded | 5 | 2021 | 108 | 0.310 |
Why?
|
| Peritonitis | 3 | 2019 | 33 | 0.300 |
Why?
|
| Gene Expression Profiling | 7 | 2020 | 712 | 0.300 |
Why?
|
| Complement System Proteins | 3 | 2020 | 127 | 0.300 |
Why?
|
| Acute Lung Injury | 2 | 2021 | 43 | 0.300 |
Why?
|
| Amino Acid Sequence | 6 | 2019 | 1589 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2014 | 502 | 0.290 |
Why?
|
| Bacterial Infections | 3 | 2019 | 139 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2018 | 449 | 0.290 |
Why?
|
| HIV Infections | 4 | 2021 | 927 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 256 | 0.290 |
Why?
|
| Toll-Like Receptor 3 | 5 | 2024 | 67 | 0.280 |
Why?
|
| Golgi Apparatus | 3 | 2016 | 65 | 0.280 |
Why?
|
| Parkinson Disease | 2 | 2020 | 118 | 0.280 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 68 | 0.280 |
Why?
|
| Blood Pressure | 3 | 2021 | 522 | 0.280 |
Why?
|
| Virus Diseases | 3 | 2022 | 112 | 0.280 |
Why?
|
| HIV-1 | 4 | 2021 | 709 | 0.280 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2019 | 31 | 0.270 |
Why?
|
| Communicable Diseases | 2 | 2018 | 83 | 0.270 |
Why?
|
| Interferon-alpha | 4 | 2023 | 99 | 0.270 |
Why?
|
| Life Style | 2 | 2019 | 330 | 0.270 |
Why?
|
| Endothelial Cells | 3 | 2022 | 177 | 0.270 |
Why?
|
| Models, Molecular | 5 | 2021 | 1137 | 0.260 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 46 | 0.260 |
Why?
|
| NLR Proteins | 3 | 2022 | 11 | 0.260 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 2 | 2017 | 3 | 0.260 |
Why?
|
| MicroRNAs | 3 | 2022 | 620 | 0.260 |
Why?
|
| Viral Proteins | 3 | 2016 | 261 | 0.260 |
Why?
|
| Cell Communication | 3 | 2021 | 127 | 0.260 |
Why?
|
| RNA, Bacterial | 2 | 2017 | 70 | 0.260 |
Why?
|
| Neisseria meningitidis | 2 | 2004 | 104 | 0.260 |
Why?
|
| Autoantigens | 1 | 2006 | 125 | 0.250 |
Why?
|
| Oligonucleotides | 3 | 2017 | 211 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2022 | 125 | 0.250 |
Why?
|
| Dysbiosis | 3 | 2022 | 56 | 0.250 |
Why?
|
| Cathepsins | 2 | 2020 | 33 | 0.250 |
Why?
|
| Retroviridae | 2 | 2018 | 72 | 0.250 |
Why?
|
| Proteome | 2 | 2023 | 142 | 0.240 |
Why?
|
| Filarioidea | 1 | 2025 | 1 | 0.240 |
Why?
|
| Microfilariae | 1 | 2025 | 2 | 0.240 |
Why?
|
| Antigens, Surface | 2 | 2003 | 192 | 0.240 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2011 | 78 | 0.240 |
Why?
|
| Filariasis | 1 | 2025 | 22 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 4 | 2016 | 883 | 0.240 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2016 | 70 | 0.240 |
Why?
|
| Pulmonary Fibrosis | 2 | 2022 | 53 | 0.240 |
Why?
|
| Aqueous Humor | 1 | 2024 | 6 | 0.240 |
Why?
|
| Adenosine Deaminase | 1 | 2024 | 16 | 0.240 |
Why?
|
| Antigens, Differentiation | 6 | 2005 | 141 | 0.240 |
Why?
|
| Butyrates | 1 | 2024 | 13 | 0.240 |
Why?
|
| Propionates | 1 | 2024 | 19 | 0.230 |
Why?
|
| Glutamine | 1 | 2025 | 47 | 0.230 |
Why?
|
| Hypertension | 2 | 2021 | 603 | 0.230 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 63 | 0.230 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2025 | 41 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 8 | 2013 | 665 | 0.230 |
Why?
|
| Acetaminophen | 2 | 2025 | 52 | 0.230 |
Why?
|
| Cataract | 1 | 2024 | 54 | 0.230 |
Why?
|
| Antibodies | 4 | 2023 | 176 | 0.230 |
Why?
|
| Haemophilus Vaccines | 1 | 2004 | 5 | 0.230 |
Why?
|
| Metadata | 1 | 2024 | 14 | 0.230 |
Why?
|
| Zellweger Syndrome | 1 | 2024 | 1 | 0.230 |
Why?
|
| Peroxisomal Disorders | 1 | 2024 | 1 | 0.230 |
Why?
|
| Citric Acid Cycle | 2 | 2024 | 26 | 0.230 |
Why?
|
| Middle Aged | 17 | 2024 | 16535 | 0.230 |
Why?
|
| T-Lymphocytes | 6 | 2024 | 969 | 0.220 |
Why?
|
| Lung | 4 | 2018 | 842 | 0.220 |
Why?
|
| Apolipoprotein C-III | 2 | 2023 | 7 | 0.220 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2004 | 44 | 0.220 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2021 | 75 | 0.220 |
Why?
|
| Transduction, Genetic | 2 | 2018 | 233 | 0.220 |
Why?
|
| Up-Regulation | 3 | 2021 | 365 | 0.220 |
Why?
|
| Models, Immunological | 3 | 2015 | 80 | 0.220 |
Why?
|
| Immunoblotting | 6 | 2018 | 190 | 0.220 |
Why?
|
| Histiocytosis | 1 | 2023 | 4 | 0.220 |
Why?
|
| Biological Transport | 2 | 2016 | 288 | 0.220 |
Why?
|
| Phosphoproteins | 4 | 2017 | 213 | 0.220 |
Why?
|
| NADPH Oxidases | 1 | 2003 | 64 | 0.220 |
Why?
|
| Base Sequence | 6 | 2021 | 1313 | 0.220 |
Why?
|
| Proteolysis | 2 | 2021 | 137 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2014 | 145 | 0.220 |
Why?
|
| Antibodies, Antinuclear | 2 | 2018 | 36 | 0.210 |
Why?
|
| Lymphocyte Antigen 96 | 4 | 2010 | 53 | 0.210 |
Why?
|
| Enzyme Inhibitors | 3 | 2021 | 346 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 398 | 0.210 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2023 | 12 | 0.210 |
Why?
|
| Transcription Factors | 6 | 2014 | 1459 | 0.210 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2004 | 138 | 0.210 |
Why?
|
| Caspases | 2 | 2016 | 165 | 0.210 |
Why?
|
| RNA, Small Interfering | 8 | 2018 | 855 | 0.210 |
Why?
|
| Listeriosis | 3 | 2016 | 30 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 676 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 4 | 2014 | 228 | 0.200 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 157 | 0.200 |
Why?
|
| Nucleotide Motifs | 3 | 2017 | 44 | 0.200 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 6 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2021 | 71 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 280 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 168 | 0.200 |
Why?
|
| Aged | 13 | 2024 | 13581 | 0.200 |
Why?
|
| Tyrosine | 2 | 2021 | 93 | 0.200 |
Why?
|
| Ciliopathies | 1 | 2022 | 10 | 0.200 |
Why?
|
| Lysine | 2 | 2017 | 76 | 0.200 |
Why?
|
| Receptors, Odorant | 1 | 2022 | 5 | 0.200 |
Why?
|
| Aldehydes | 1 | 2022 | 16 | 0.200 |
Why?
|
| Interferon Regulatory Factor-3 | 8 | 2024 | 91 | 0.200 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2019 | 11 | 0.200 |
Why?
|
| Nanoparticles | 2 | 2018 | 499 | 0.200 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2016 | 70 | 0.190 |
Why?
|
| Binge-Eating Disorder | 1 | 2022 | 11 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2024 | 356 | 0.190 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 1384 | 0.190 |
Why?
|
| Cell Membrane Structures | 1 | 2021 | 8 | 0.190 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2013 | 64 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 621 | 0.190 |
Why?
|
| Protein Aggregation, Pathological | 2 | 2019 | 17 | 0.190 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 10 | 0.190 |
Why?
|
| Tauopathies | 1 | 2021 | 15 | 0.190 |
Why?
|
| Acetylation | 2 | 2019 | 111 | 0.190 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 56 | 0.190 |
Why?
|
| Cholesterol Esters | 1 | 2021 | 10 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 53 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 16 | 0.190 |
Why?
|
| Neuronal Apoptosis-Inhibitory Protein | 1 | 2021 | 2 | 0.190 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 162 | 0.180 |
Why?
|
| Primary Cell Culture | 5 | 2021 | 75 | 0.180 |
Why?
|
| Microscopy, Atomic Force | 2 | 2012 | 29 | 0.180 |
Why?
|
| SELEX Aptamer Technique | 2 | 2017 | 2 | 0.180 |
Why?
|
| Adult | 14 | 2024 | 15985 | 0.180 |
Why?
|
| Intracellular Space | 2 | 2011 | 33 | 0.180 |
Why?
|
| Cations | 2 | 2019 | 63 | 0.180 |
Why?
|
| Cholesterol, LDL | 3 | 2021 | 105 | 0.180 |
Why?
|
| Drug Discovery | 2 | 2019 | 92 | 0.180 |
Why?
|
| Endocytosis | 3 | 2013 | 148 | 0.180 |
Why?
|
| Docosahexaenoic Acids | 1 | 2021 | 31 | 0.180 |
Why?
|
| Hemeproteins | 2 | 2014 | 17 | 0.180 |
Why?
|
| Complement Activation | 3 | 2017 | 53 | 0.180 |
Why?
|
| Ubiquitin | 1 | 2021 | 95 | 0.180 |
Why?
|
| Liposomes | 2 | 2019 | 100 | 0.180 |
Why?
|
| RAW 264.7 Cells | 4 | 2022 | 48 | 0.180 |
Why?
|
| Fatty Acid Binding Protein 3 | 1 | 2020 | 3 | 0.180 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2021 | 63 | 0.180 |
Why?
|
| DNA, Protozoan | 2 | 2014 | 35 | 0.180 |
Why?
|
| Obesity | 3 | 2022 | 1192 | 0.180 |
Why?
|
| Neurogranin | 1 | 2020 | 9 | 0.180 |
Why?
|
| Cholestasis | 1 | 2021 | 54 | 0.180 |
Why?
|
| Saliva | 1 | 2021 | 96 | 0.180 |
Why?
|
| Ferritins | 1 | 2020 | 32 | 0.180 |
Why?
|
| Spatial Learning | 1 | 2020 | 2 | 0.180 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 5197 | 0.180 |
Why?
|
| Cilia | 1 | 2022 | 157 | 0.180 |
Why?
|
| Autophagosomes | 1 | 2020 | 11 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 183 | 0.180 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2022 | 85 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 169 | 0.180 |
Why?
|
| Phospholipase C gamma | 1 | 2020 | 9 | 0.170 |
Why?
|
| Antihypertensive Agents | 2 | 2019 | 173 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2023 | 317 | 0.170 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 376 | 0.170 |
Why?
|
| Autoantibodies | 2 | 2014 | 175 | 0.170 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 62 | 0.170 |
Why?
|
| Long-Term Potentiation | 1 | 2020 | 43 | 0.170 |
Why?
|
| Salmonella Infections | 1 | 2020 | 38 | 0.170 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 194 | 0.170 |
Why?
|
| Kangai-1 Protein | 1 | 2019 | 3 | 0.170 |
Why?
|
| Oxidative Stress | 3 | 2022 | 282 | 0.170 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2019 | 2 | 0.170 |
Why?
|
| NIMA-Related Kinases | 1 | 2019 | 5 | 0.170 |
Why?
|
| Salmonella typhimurium | 1 | 2020 | 80 | 0.170 |
Why?
|
| Ileus | 1 | 2019 | 6 | 0.170 |
Why?
|
| Peptidomimetics | 1 | 2019 | 5 | 0.170 |
Why?
|
| Down-Regulation | 4 | 2021 | 306 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 59 | 0.160 |
Why?
|
| Liver Diseases | 2 | 2018 | 136 | 0.160 |
Why?
|
| Immunization | 4 | 2015 | 130 | 0.160 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 2 | 2016 | 6 | 0.160 |
Why?
|
| Stochastic Processes | 1 | 2019 | 26 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 279 | 0.160 |
Why?
|
| Extracellular Traps | 2 | 2021 | 40 | 0.160 |
Why?
|
| Crystallography, X-Ray | 3 | 2020 | 423 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2019 | 181 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2020 | 101 | 0.160 |
Why?
|
| Gene Expression | 4 | 2020 | 807 | 0.160 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2020 | 23 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 525 | 0.160 |
Why?
|
| Galectins | 1 | 2018 | 7 | 0.160 |
Why?
|
| Influenza A virus | 2 | 2013 | 117 | 0.160 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 72 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2021 | 376 | 0.160 |
Why?
|
| DNA, Viral | 2 | 2010 | 228 | 0.160 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 11 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 325 | 0.160 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 455 | 0.160 |
Why?
|
| Antigen-Antibody Complex | 4 | 2012 | 49 | 0.160 |
Why?
|
| CD36 Antigens | 2 | 2021 | 26 | 0.160 |
Why?
|
| Gene Library | 1 | 2019 | 99 | 0.160 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 129 | 0.160 |
Why?
|
| Protein Conformation | 4 | 2022 | 774 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 250 | 0.150 |
Why?
|
| Cohort Studies | 6 | 2022 | 2479 | 0.150 |
Why?
|
| Mutation | 3 | 2023 | 2471 | 0.150 |
Why?
|
| Arginine | 1 | 2019 | 114 | 0.150 |
Why?
|
| Lymphocyte Activation | 8 | 2016 | 742 | 0.150 |
Why?
|
| Membrane Microdomains | 2 | 2016 | 48 | 0.150 |
Why?
|
| Luciferases | 2 | 2013 | 109 | 0.150 |
Why?
|
| Swine | 1 | 2019 | 349 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 498 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 164 | 0.150 |
Why?
|
| RNA, Viral | 5 | 2012 | 265 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 225 | 0.150 |
Why?
|
| Protein Folding | 3 | 2015 | 261 | 0.150 |
Why?
|
| Colchicine | 1 | 2018 | 27 | 0.150 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2018 | 8 | 0.150 |
Why?
|
| Hypertension, Portal | 1 | 2018 | 15 | 0.150 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2021 | 389 | 0.150 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2017 | 1 | 0.150 |
Why?
|
| Protein Stability | 1 | 2018 | 85 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 131 | 0.150 |
Why?
|
| Chemokine CCL17 | 1 | 2017 | 1 | 0.150 |
Why?
|
| Staphylococcus aureus | 2 | 2017 | 161 | 0.150 |
Why?
|
| RNA Interference | 4 | 2016 | 592 | 0.150 |
Why?
|
| Incretins | 1 | 2017 | 7 | 0.150 |
Why?
|
| Dermatitis, Contact | 1 | 2017 | 12 | 0.150 |
Why?
|
| Interleukin-8 | 5 | 2019 | 84 | 0.140 |
Why?
|
| Ceramides | 1 | 2017 | 25 | 0.140 |
Why?
|
| Cyclodextrins | 1 | 2017 | 13 | 0.140 |
Why?
|
| Seizures | 1 | 2018 | 118 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 71 | 0.140 |
Why?
|
| Chemotaxis | 1 | 2017 | 47 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 23 | 0.140 |
Why?
|
| Interleukin-4 | 1 | 2017 | 141 | 0.140 |
Why?
|
| Viral Load | 5 | 2021 | 229 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 277 | 0.140 |
Why?
|
| Friends | 1 | 2017 | 29 | 0.140 |
Why?
|
| Phosphoserine | 1 | 2017 | 10 | 0.140 |
Why?
|
| Spores, Bacterial | 1 | 2017 | 3 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2021 | 268 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 275 | 0.140 |
Why?
|
| Protein Phosphatase 2 | 1 | 2017 | 10 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 41 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2024 | 1066 | 0.140 |
Why?
|
| HeLa Cells | 2 | 2021 | 531 | 0.140 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 151 | 0.140 |
Why?
|
| Carotid Arteries | 1 | 2017 | 59 | 0.140 |
Why?
|
| Amino Acid Motifs | 2 | 2014 | 153 | 0.140 |
Why?
|
| Agammaglobulinemia | 1 | 2017 | 8 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 191 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 9 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 2016 | 3 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2016 | 598 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 203 | 0.140 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2016 | 7 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 118 | 0.140 |
Why?
|
| Diabetic Neuropathies | 1 | 2016 | 8 | 0.140 |
Why?
|
| Transfection | 7 | 2013 | 676 | 0.140 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 26 | 0.140 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2016 | 11 | 0.140 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2016 | 3 | 0.140 |
Why?
|
| Pinocytosis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2017 | 71 | 0.140 |
Why?
|
| Software | 2 | 2024 | 374 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2017 | 124 | 0.140 |
Why?
|
| Dental Calculus | 1 | 2016 | 2 | 0.140 |
Why?
|
| Time Factors | 5 | 2020 | 3618 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2019 | 604 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2015 | 58 | 0.140 |
Why?
|
| Receptors, IgG | 3 | 2018 | 36 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 27 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 647 | 0.130 |
Why?
|
| Simvastatin | 1 | 2016 | 28 | 0.130 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 32 | 0.130 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2016 | 7 | 0.130 |
Why?
|
| Nephritis | 1 | 2016 | 8 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 176 | 0.130 |
Why?
|
| DEAD Box Protein 58 | 3 | 2011 | 18 | 0.130 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2016 | 26 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 113 | 0.130 |
Why?
|
| Sulfonylurea Compounds | 1 | 2016 | 14 | 0.130 |
Why?
|
| Liver X Receptors | 1 | 2016 | 8 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2017 | 197 | 0.130 |
Why?
|
| Dermatitis | 1 | 2016 | 29 | 0.130 |
Why?
|
| Immunity, Heterologous | 1 | 2016 | 11 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 3 | 2018 | 858 | 0.130 |
Why?
|
| ras Proteins | 1 | 2016 | 78 | 0.130 |
Why?
|
| Gadolinium | 2 | 2014 | 102 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 225 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 807 | 0.130 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Syndrome | 2 | 2014 | 173 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2017 | 146 | 0.130 |
Why?
|
| Phase Transition | 1 | 2016 | 19 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 93 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 330 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 116 | 0.130 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 32 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 131 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2018 | 943 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 603 | 0.120 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 38 | 0.120 |
Why?
|
| Gingiva | 1 | 2015 | 7 | 0.120 |
Why?
|
| Desoxycorticosterone Acetate | 3 | 2021 | 3 | 0.120 |
Why?
|
| Streptococcus pyogenes | 1 | 2015 | 27 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2016 | 160 | 0.120 |
Why?
|
| Lipofuscin | 1 | 2015 | 4 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 118 | 0.120 |
Why?
|
| Mice, Inbred C3H | 2 | 2013 | 175 | 0.120 |
Why?
|
| Silicon Dioxide | 2 | 2022 | 59 | 0.120 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2015 | 18 | 0.120 |
Why?
|
| Mice, Mutant Strains | 5 | 2018 | 304 | 0.120 |
Why?
|
| Calgranulin A | 1 | 2014 | 5 | 0.120 |
Why?
|
| Calcium | 1 | 2018 | 558 | 0.120 |
Why?
|
| Hyperoxia | 1 | 2014 | 16 | 0.120 |
Why?
|
| Diet | 1 | 2019 | 637 | 0.120 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 14 | 0.120 |
Why?
|
| Reactive Nitrogen Species | 1 | 2014 | 7 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2016 | 129 | 0.120 |
Why?
|
| Vaccines | 1 | 2016 | 97 | 0.120 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2014 | 11 | 0.120 |
Why?
|
| Colon | 1 | 2015 | 139 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 213 | 0.120 |
Why?
|
| Prions | 1 | 2014 | 24 | 0.120 |
Why?
|
| Peritoneum | 1 | 2014 | 25 | 0.120 |
Why?
|
| Phagosomes | 2 | 2012 | 44 | 0.110 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 22 | 0.110 |
Why?
|
| Pseudomonas Infections | 1 | 2014 | 52 | 0.110 |
Why?
|
| Light | 1 | 2015 | 201 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 229 | 0.110 |
Why?
|
| Saponins | 1 | 2014 | 28 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 81 | 0.110 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 289 | 0.110 |
Why?
|
| Bystander Effect | 1 | 2013 | 5 | 0.110 |
Why?
|
| Biofilms | 1 | 2015 | 70 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2014 | 180 | 0.110 |
Why?
|
| Systems Biology | 1 | 2013 | 28 | 0.110 |
Why?
|
| Colitis | 2 | 2015 | 76 | 0.110 |
Why?
|
| Phospholipids | 1 | 2014 | 79 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 100 | 0.110 |
Why?
|
| Fas Ligand Protein | 1 | 2013 | 39 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 57 | 0.110 |
Why?
|
| eIF-2 Kinase | 1 | 2013 | 10 | 0.110 |
Why?
|
| Immunity | 1 | 2014 | 97 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 137 | 0.110 |
Why?
|
| Crystallins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Vaccination | 3 | 2022 | 344 | 0.110 |
Why?
|
| Peptides | 1 | 2016 | 551 | 0.110 |
Why?
|
| Static Electricity | 1 | 2013 | 165 | 0.100 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2012 | 11 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2024 | 147 | 0.100 |
Why?
|
| Poly dA-dT | 2 | 2009 | 7 | 0.100 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2025 | 18 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2013 | 84 | 0.100 |
Why?
|
| Malaria | 1 | 2014 | 100 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2019 | 1172 | 0.100 |
Why?
|
| Annexin A1 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 4 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 477 | 0.100 |
Why?
|
| Genetic Vectors | 3 | 2018 | 820 | 0.100 |
Why?
|
| DNA, B-Form | 1 | 2012 | 2 | 0.100 |
Why?
|
| Focal Adhesions | 1 | 2012 | 23 | 0.100 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 209 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 73 | 0.100 |
Why?
|
| Contrast Media | 1 | 2014 | 414 | 0.090 |
Why?
|
| Neointima | 1 | 2011 | 19 | 0.090 |
Why?
|
| Aortic Valve | 2 | 2024 | 170 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1983 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2012 | 137 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2024 | 5262 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 114 | 0.090 |
Why?
|
| Escherichia coli | 3 | 2010 | 688 | 0.090 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 290 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2011 | 61 | 0.090 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 68 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2013 | 192 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 183 | 0.090 |
Why?
|
| Coinfection | 1 | 2011 | 45 | 0.090 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 7 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 31 | 0.090 |
Why?
|
| Spleen | 2 | 2025 | 486 | 0.090 |
Why?
|
| Cathepsin L | 1 | 2010 | 20 | 0.090 |
Why?
|
| Cathepsin B | 1 | 2010 | 13 | 0.090 |
Why?
|
| Albuminuria | 2 | 2021 | 24 | 0.090 |
Why?
|
| DNA Virus Infections | 1 | 2010 | 9 | 0.090 |
Why?
|
| Young Adult | 5 | 2024 | 4396 | 0.090 |
Why?
|
| Tularemia | 1 | 2010 | 17 | 0.090 |
Why?
|
| Francisella tularensis | 1 | 2010 | 23 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2012 | 156 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2010 | 14 | 0.090 |
Why?
|
| DNA Viruses | 1 | 2010 | 15 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 252 | 0.090 |
Why?
|
| Sporozoites | 1 | 2009 | 4 | 0.080 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2010 | 37 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 136 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2010 | 80 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2018 | 93 | 0.080 |
Why?
|
| Plasmodium berghei | 1 | 2009 | 20 | 0.080 |
Why?
|
| Nitriles | 1 | 2010 | 62 | 0.080 |
Why?
|
| RNA Polymerase III | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2011 | 274 | 0.080 |
Why?
|
| Immunomodulation | 2 | 2021 | 27 | 0.080 |
Why?
|
| Polyphosphates | 1 | 2009 | 12 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2009 | 58 | 0.080 |
Why?
|
| RNA Viruses | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cell Line, Transformed | 3 | 2016 | 97 | 0.080 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 160 | 0.080 |
Why?
|
| Antimalarials | 1 | 2009 | 68 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1297 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 483 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2004 | 79 | 0.080 |
Why?
|
| Neutrophil Infiltration | 2 | 2022 | 61 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 516 | 0.080 |
Why?
|
| Locomotion | 1 | 2009 | 111 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 98 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1132 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2023 | 176 | 0.080 |
Why?
|
| Aluminum Compounds | 1 | 2008 | 10 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 306 | 0.080 |
Why?
|
| Chaperonin 10 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 189 | 0.080 |
Why?
|
| Streptococcus agalactiae | 1 | 2008 | 80 | 0.080 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2008 | 15 | 0.080 |
Why?
|
| Deoxyribose | 1 | 2008 | 1 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2012 | 472 | 0.080 |
Why?
|
| Trypanosoma cruzi | 1 | 2008 | 49 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 37 | 0.070 |
Why?
|
| Astrocytes | 2 | 2021 | 116 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2008 | 29 | 0.070 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 116 | 0.070 |
Why?
|
| Complement C5a | 2 | 2020 | 5 | 0.070 |
Why?
|
| Doxorubicin | 2 | 2021 | 99 | 0.070 |
Why?
|
| Psoriasis | 1 | 2008 | 51 | 0.070 |
Why?
|
| Biological Transport, Active | 2 | 2006 | 39 | 0.070 |
Why?
|
| Models, Animal | 2 | 2021 | 222 | 0.070 |
Why?
|
| Cell Separation | 2 | 2010 | 147 | 0.070 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 69 | 0.070 |
Why?
|
| DNA, Single-Stranded | 1 | 2008 | 100 | 0.070 |
Why?
|
| Host-Parasite Interactions | 2 | 2008 | 54 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 89 | 0.070 |
Why?
|
| Self Tolerance | 1 | 2006 | 18 | 0.070 |
Why?
|
| Peptide Hydrolases | 2 | 2020 | 80 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 388 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 1471 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2022 | 745 | 0.070 |
Why?
|
| Sepsis | 1 | 2010 | 282 | 0.070 |
Why?
|
| Receptors, Mitogen | 1 | 2006 | 6 | 0.070 |
Why?
|
| Pandemics | 2 | 2022 | 629 | 0.070 |
Why?
|
| Dengue Virus | 1 | 2006 | 95 | 0.060 |
Why?
|
| Bordetella Infections | 1 | 2005 | 2 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2020 | 370 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 1525 | 0.060 |
Why?
|
| Antigens, Fungal | 1 | 2006 | 55 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 2007 | 134 | 0.060 |
Why?
|
| Lipids | 2 | 2019 | 307 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2019 | 260 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 677 | 0.060 |
Why?
|
| Bacillus anthracis | 2 | 2017 | 12 | 0.060 |
Why?
|
| Plasmids | 2 | 2004 | 283 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 832 | 0.060 |
Why?
|
| Terpenes | 2 | 2016 | 25 | 0.060 |
Why?
|
| Deoxyadenosines | 1 | 2024 | 3 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2005 | 87 | 0.060 |
Why?
|
| Phacoemulsification | 1 | 2024 | 7 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 194 | 0.060 |
Why?
|
| Poxviridae | 1 | 2004 | 5 | 0.060 |
Why?
|
| Allergy and Immunology | 1 | 2024 | 7 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2006 | 141 | 0.060 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2024 | 4 | 0.060 |
Why?
|
| Carboxy-Lyases | 1 | 2024 | 6 | 0.060 |
Why?
|
| Hydro-Lyases | 1 | 2024 | 8 | 0.060 |
Why?
|
| Macular Degeneration | 2 | 2019 | 179 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2024 | 27 | 0.060 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 18 | 0.060 |
Why?
|
| Peroxisomes | 1 | 2024 | 10 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2024 | 3131 | 0.060 |
Why?
|
| Listeria monocytogenes | 2 | 2016 | 33 | 0.060 |
Why?
|
| Nucleosides | 1 | 2023 | 11 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2023 | 72 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2003 | 22 | 0.050 |
Why?
|
| Pentoxifylline | 1 | 2003 | 9 | 0.050 |
Why?
|
| Melphalan | 1 | 2003 | 22 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2024 | 166 | 0.050 |
Why?
|
| CD40 Antigens | 1 | 2023 | 60 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2003 | 31 | 0.050 |
Why?
|
| Calibration | 1 | 2023 | 64 | 0.050 |
Why?
|
| Solubility | 2 | 2018 | 176 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2003 | 31 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 304 | 0.050 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2003 | 25 | 0.050 |
Why?
|
| Cell Movement | 2 | 2017 | 425 | 0.050 |
Why?
|
| Sarcoma | 1 | 2003 | 36 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2024 | 230 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 8 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2002 | 6 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 324 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2019 | 106 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2002 | 22 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 193 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 737 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2003 | 117 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 42 | 0.050 |
Why?
|
| Culture Media | 1 | 2003 | 77 | 0.050 |
Why?
|
| Methylation | 2 | 2015 | 127 | 0.050 |
Why?
|
| Extracellular Space | 2 | 2018 | 31 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2002 | 22 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2022 | 139 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 89 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2022 | 28 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2022 | 25 | 0.050 |
Why?
|
| Genome | 1 | 2024 | 253 | 0.050 |
Why?
|
| Cecum | 1 | 2022 | 15 | 0.050 |
Why?
|
| Cell Wall | 1 | 2003 | 113 | 0.050 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2022 | 64 | 0.050 |
Why?
|
| Chemokine CCL5 | 3 | 2009 | 33 | 0.050 |
Why?
|
| Porins | 1 | 2002 | 79 | 0.050 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2021 | 11 | 0.050 |
Why?
|
| Blood Cells | 2 | 2015 | 17 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2021 | 18 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2021 | 18 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 1937 | 0.050 |
Why?
|
| Nanotubes | 1 | 2021 | 23 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 106 | 0.050 |
Why?
|
| Biopolymers | 1 | 2002 | 70 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 70 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 94 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2021 | 41 | 0.050 |
Why?
|
| Macaca | 1 | 2021 | 30 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 144 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2024 | 251 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2021 | 77 | 0.050 |
Why?
|
| Vaccinia virus | 2 | 2013 | 73 | 0.050 |
Why?
|
| Streptozocin | 1 | 2021 | 21 | 0.050 |
Why?
|
| Health | 1 | 2021 | 32 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 387 | 0.050 |
Why?
|
| HIV | 1 | 2021 | 69 | 0.050 |
Why?
|
| Epidemics | 1 | 2021 | 22 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2021 | 139 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 196 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2022 | 97 | 0.050 |
Why?
|
| Integrins | 1 | 2021 | 106 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2021 | 43 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 49 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2012 | 1470 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2021 | 57 | 0.040 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2021 | 79 | 0.040 |
Why?
|
| Cystatin B | 1 | 2020 | 1 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 35 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 323 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 264 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 298 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 191 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 260 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2021 | 68 | 0.040 |
Why?
|
| Serine | 1 | 2020 | 83 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 186 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 5082 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 305 | 0.040 |
Why?
|
| Home Care Services | 1 | 2021 | 102 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 258 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 248 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 194 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 307 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 207 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 184 | 0.040 |
Why?
|
| Melanoma | 1 | 2003 | 335 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 424 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 123 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 305 | 0.040 |
Why?
|
| omega-Chloroacetophenone | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2018 | 20 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 49 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2019 | 59 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 2019 | 107 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 643 | 0.040 |
Why?
|
| alpha-2-HS-Glycoprotein | 1 | 2018 | 2 | 0.040 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2018 | 5 | 0.040 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 12 | 0.040 |
Why?
|
| Piracetam | 1 | 2018 | 8 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 77 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2013 | 434 | 0.040 |
Why?
|
| Potassium | 1 | 2019 | 110 | 0.040 |
Why?
|
| Minerals | 1 | 2018 | 19 | 0.040 |
Why?
|
| Collagen | 1 | 2019 | 119 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 38 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 454 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 52 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 651 | 0.040 |
Why?
|
| Colloids | 1 | 2018 | 51 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 332 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2003 | 405 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2017 | 7 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2017 | 31 | 0.040 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 21 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2018 | 37 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 1 | 2017 | 28 | 0.040 |
Why?
|
| Calcinosis | 1 | 2018 | 79 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 36 | 0.040 |
Why?
|
| Cell Survival | 2 | 2014 | 558 | 0.040 |
Why?
|
| Telomere | 1 | 2017 | 48 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 82 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2017 | 58 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 164 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 72 | 0.040 |
Why?
|
| Fluorescence Polarization | 1 | 2017 | 32 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 65 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 237 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2017 | 185 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2017 | 79 | 0.040 |
Why?
|
| Nigericin | 1 | 2017 | 4 | 0.040 |
Why?
|
| Pyrin Domain | 1 | 2017 | 3 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2017 | 119 | 0.040 |
Why?
|
| Leukocidins | 1 | 2017 | 8 | 0.040 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2017 | 2 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2018 | 125 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Proteins | 1 | 2022 | 743 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 969 | 0.030 |
Why?
|
| Splenic Diseases | 1 | 2016 | 15 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2016 | 20 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cholagogues and Choleretics | 1 | 2016 | 5 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 65 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 14 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 231 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 558 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 378 | 0.030 |
Why?
|
| Oxalates | 1 | 2016 | 17 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 254 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 97 | 0.030 |
Why?
|
| Invertebrates | 1 | 2016 | 21 | 0.030 |
Why?
|
| Plants | 1 | 2016 | 42 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 46 | 0.030 |
Why?
|
| Taurine | 1 | 2015 | 5 | 0.030 |
Why?
|
| Germ-Free Life | 1 | 2015 | 8 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 144 | 0.030 |
Why?
|
| Hippocampus | 1 | 2017 | 243 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 305 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 466 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 148 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 77 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 99 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 87 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 381 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 9 | 0.030 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2016 | 132 | 0.030 |
Why?
|
| Complement C3c | 1 | 2015 | 1 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2015 | 45 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2015 | 5 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 218 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 71 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2015 | 54 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2015 | 21 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 661 | 0.030 |
Why?
|
| CD18 Antigens | 1 | 2015 | 30 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 21 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 335 | 0.030 |
Why?
|
| Kinetics | 2 | 2008 | 738 | 0.030 |
Why?
|
| Calgranulin B | 1 | 2014 | 6 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 71 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 281 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 44 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2017 | 351 | 0.030 |
Why?
|
| Web Browser | 1 | 2014 | 5 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 53 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2014 | 29 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 59 | 0.030 |
Why?
|
| RNA Editing | 1 | 2014 | 21 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 447 | 0.030 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2005 | 33 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 5958 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 292 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 36 | 0.030 |
Why?
|
| Complement C5 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Complement C1q | 1 | 2014 | 8 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2014 | 23 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 273 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2014 | 30 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 854 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2014 | 62 | 0.030 |
Why?
|
| Podocytes | 1 | 2013 | 8 | 0.030 |
Why?
|
| CHO Cells | 2 | 2006 | 190 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2013 | 15 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 793 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 85 | 0.030 |
Why?
|
| Complement Pathway, Alternative | 1 | 2014 | 27 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2008 | 344 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 64 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 138 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| I-kappa B Kinase | 2 | 2004 | 48 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2013 | 16 | 0.030 |
Why?
|
| Plasmodium | 1 | 2014 | 29 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2013 | 26 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 164 | 0.030 |
Why?
|
| Cricetinae | 2 | 2006 | 376 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 65 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2367 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2006 | 179 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2014 | 154 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2015 | 474 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 193 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 124 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 661 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2014 | 353 | 0.030 |
Why?
|
| Vinculin | 1 | 2012 | 3 | 0.030 |
Why?
|
| Camptothecin | 1 | 2012 | 23 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 16 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 130 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 67 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 109 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 873 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 47 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 53 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 51 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 443 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 118 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 930 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 230 | 0.020 |
Why?
|
| Neuroglia | 1 | 2012 | 79 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 194 | 0.020 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2011 | 10 | 0.020 |
Why?
|
| Candidiasis | 1 | 2011 | 40 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 752 | 0.020 |
Why?
|
| Candida | 1 | 2011 | 34 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2012 | 217 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 94 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 194 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 78 | 0.020 |
Why?
|
| Greece | 1 | 2010 | 3 | 0.020 |
Why?
|
| Germany | 1 | 2010 | 53 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2010 | 37 | 0.020 |
Why?
|
| Uridine | 1 | 2010 | 16 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2010 | 28 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 126 | 0.020 |
Why?
|
| Ribose | 1 | 2009 | 3 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2010 | 75 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2009 | 28 | 0.020 |
Why?
|
| X-Rays | 1 | 2009 | 45 | 0.020 |
Why?
|
| Oligoribonucleotides | 1 | 2009 | 14 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 194 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2009 | 71 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1002 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2009 | 113 | 0.020 |
Why?
|
| Cross Infection | 1 | 2010 | 154 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 17 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2008 | 22 | 0.020 |
Why?
|
| Retroelements | 1 | 2008 | 39 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7622 | 0.020 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2008 | 7 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2009 | 195 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2008 | 13 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 149 | 0.020 |
Why?
|
| Dinucleoside Phosphates | 1 | 2008 | 32 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2008 | 49 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 103 | 0.020 |
Why?
|
| Virus Activation | 1 | 2006 | 25 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2007 | 43 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 49 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2008 | 139 | 0.020 |
Why?
|
| Glycation End Products, Advanced | 1 | 2006 | 19 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 9 | 0.020 |
Why?
|
| Neurons | 1 | 2012 | 862 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2008 | 680 | 0.020 |
Why?
|
| Cricetulus | 1 | 2006 | 102 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2010 | 454 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2006 | 8 | 0.020 |
Why?
|
| Dynamins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2006 | 21 | 0.020 |
Why?
|
| Clathrin | 1 | 2006 | 23 | 0.020 |
Why?
|
| Bordetella bronchiseptica | 1 | 2005 | 2 | 0.020 |
Why?
|
| Bordetella parapertussis | 1 | 2005 | 2 | 0.020 |
Why?
|
| K562 Cells | 1 | 2006 | 58 | 0.020 |
Why?
|
| Viral Fusion Proteins | 1 | 2006 | 74 | 0.020 |
Why?
|
| Bordetella pertussis | 1 | 2005 | 10 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2006 | 60 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 54 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 78 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 182 | 0.020 |
Why?
|
| Lipid A | 1 | 2005 | 70 | 0.020 |
Why?
|
| Dogs | 1 | 2006 | 307 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 33 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 178 | 0.020 |
Why?
|
| Electroporation | 1 | 2005 | 32 | 0.020 |
Why?
|
| Biological Assay | 1 | 2005 | 54 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 1918 | 0.010 |
Why?
|
| Zymosan | 1 | 2003 | 23 | 0.010 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2003 | 22 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 32 | 0.010 |
Why?
|
| Biotinylation | 1 | 2003 | 38 | 0.010 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2003 | 6 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 106 | 0.010 |
Why?
|
| Extremities | 1 | 2003 | 50 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 42 | 0.010 |
Why?
|
| Cysteine | 1 | 2003 | 109 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 359 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2049 | 0.010 |
Why?
|
| B7-2 Antigen | 1 | 2002 | 32 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 296 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 697 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 212 | 0.010 |
Why?
|